Granahan Investment Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-190,618
| Closed | -$1.81M | – | 190 |
|
|
2023
Q4 | $1.81M | Buy |
190,618
+45,362
| +31% | +$430K | 0.06% | 162 |
|
|
2023
Q3 | $1.73M | Sell |
145,256
-44,646
| -24% | -$531K | 0.06% | 162 |
|
|
2023
Q2 | $4.65M | Buy |
189,902
+77,768
| +69% | +$1.91M | 0.14% | 136 |
|
|
2023
Q1 | $3.51M | Buy |
112,134
+43,096
| +62% | +$1.35M | 0.11% | 140 |
|
|
2022
Q4 | $4.86M | Buy |
69,038
+24,296
| +54% | +$1.71M | 0.15% | 133 |
|
|
2022
Q3 | $3.85M | Buy |
44,742
+17,126
| +62% | +$1.47M | 0.13% | 139 |
|
|
2022
Q2 | $2.28M | Buy |
27,616
+10,647
| +63% | +$881K | 0.08% | 155 |
|
|
2022
Q1 | $2.82M | Buy |
16,969
+5,343
| +46% | +$888K | 0.07% | 160 |
|
|
2021
Q4 | $1.94M | Buy |
+11,626
| New | +$1.94M | 0.04% | 177 |
|